Entropy Neurodynamics Ltd (enp) Logo

Entropy Neurodynamics Ltd (ENP)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
Stock Scores NEW
News
Announcements

ENP ASX Chart

Snapshot

Entropy Neurodynamics Limited (ENP, formerly Tryptamine Therapeutics Limited), is a clinical-stage biotechnology company focused on developing patented, original formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -7.37%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,203 of 2,354
Sector Rank 84 of 244

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies -
EPS -$0.003
DPS $0.00
Book Value Per Share $0.005

Broker Consensus

ENP is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Hawthorn East VIC 3123
Website www.tryptherapeutics.com
Registry Automic Group
Auditor BDO Audit Pty Ltd
Date Listed 18 Dec 2018

Upcoming Calendar (Forecasted)

Date Event
12/11/2026 AGM
26/02/2027 Report (Interim)
27/08/2027 Report (Prelim)
27/08/2027 Report (Annual)

Former Company Names

  • Tryptamine Therapeutics Limited (TYP), 20/11/2025
  • Exopharm Limited (EX1), 03/05/2024

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ENP directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
14/10/26 Herwig Janssen Issued 623,441 $0.04 $25,000 Director remuneration
07/08/26 Herwig Janssen Issued 766,871 $0.033 $25,000 Director remuneration
13/05/26 Jason Carroll Buy +538,236 $0.036 $19,376 On-market trade
12/05/26 Jason Carroll Buy +750,000 $0.035 $26,250 On-market trade
17/04/26 Herwig Janssen Issued 726,195 $0.034 $25,000 Director remuneration
14/04/26 Herwig Janssen Issued 1,470,588 $0.034 $50,000 Placement
14/04/26 Jason Carroll Issued 4,411,764 $0.034 $150,000 Placement
14/04/26 Daniel Tillett Issued 5,000,000 $0.034 $170,000 Placement
14/04/26 Christopher Ntoumenopoulos Issued 2,941,176 $0.034 $100,000 Placement
06/03/26 Jason Carroll Transfer 2,500,000 $0.03 $75,000 Off-market transfer
06/02/26 Jason Carroll Buy +1,000,000 $0.03 $30,000 On-market trade
03/02/26 Jason Carroll Buy +1,000,000 $0.03 $30,000 On-market trade
16/01/26 Herwig Janssen Issued 1,931,012 $0.033 $64,109 Director remuneration
19/12/25 Christopher Ntoumenopoulos Issued 10,000,000 $0.034 $340,000 Issue of options
19/12/25 Jason Carroll Issued 10,000,000 $0.034 $340,000 Issue of options
19/12/25 Daniel Tillett Issued 10,000,000 $0.034 $340,000 Issue of options
19/12/25 Herwig Janssen Issued 10,000,000 $0.034 $340,000 Issue of options
19/12/25 Gage Jull Issued 10,000,000 $0.034 $340,000 Issue of options
31/03/25 Christopher Ntoumenopoulos Issued 5,000,000 $0.036 $180,000 As advised by the company
31/03/25 Christopher Ntoumenopoulos Issued 10,000,000 $0.02 $200,000 As advised by the company
31/03/25 Jason Carroll Issued 7,500,000 $0.036 $270,000 As advised by the company
31/03/25 Jason Carroll Issued 15,000,000 $0.02 $300,000 As advised by the company
31/03/25 Daniel Tillett Issued 12,250,000 $0.036 $441,000 Issue of options
31/03/25 Daniel Tillett Issued 25,000,000 $0.036 $900,000 As advised by the company
31/03/25 Daniel Tillett Issued 50,000,000 $0.02 $1,000,000 As advised by the company
Show All

Director Interests

The current holdings of ENP directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Herwig Janssen 14/10/2026 39,304,107 N/A 24,375,000 N/A
Gage Jull 30/06/2026 1,677,205 N/A 20,124,800 N/A
Jason Carroll 30/06/2026 62,500,000 N/A 81,142,190 N/A
Daniel Tillett 30/06/2026 67,000,000 N/A 47,250,000 N/A
Christopher Ntoumenopoulos 30/06/2026 N/A 19,191,176 49,046,580 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 19, 2026.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Dr William James Garner 222,454,729 13.63%
Citicorp Nominees Pty Limited 99,376,907 6.09%
Dr Daniel Tillett 67,000,000 4.10%
Netwealth Investments Limited <Wrap Services A/C> 63,953,087 3.92%
Jason Alan Carroll 62,500,000 3.83%
Netwealth Investments Limited <Super Services A/C> 49,841,682 3.05%
Herwig Janssen 38,680,666 2.37%
BNP Paribas Noms Pty Ltd 35,336,010 2.16%
Mr Phillip Richard Perry 26,841,176 1.64%
The Trust Company (Australia) Limited <Sbf A/C> 24,532,993 1.50%
BNP Paribas Nominees Pty Ltd <IB AU Noms Retailclient> 21,059,974 1.29%
Ludwig Criel 16,750,000 1.03%
BNP Paribas Nominees Pty Ltd <Clearstream> 16,679,450 1.02%
Kli Pty Ltd <The T Teh'S Family A/C> 15,000,000 0.92%
Mr James Kuo 14,806,471 0.91%
Non Correlated Capital Pty Ltd <Investius Pb Micro Cap A/C> 14,111,765 0.86%
Sobol Capital Pty Ltd <Sobol Capital A/C> 13,750,000 0.84%
HSBC Custody Nominees (Australia) Limited 13,308,774 0.82%
Berne No 132 Nominees Pty Ltd <791994 A/C> 12,294,118 0.75%
Solequest Pty Ltd 12,000,000 0.74%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 405 431 186 808 837 2,667

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
William Garner 19/08/2026 222,454,729 13.63
Citicorp Nominees Pty Limited 19/08/2026 99,376,907 6.09

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.03 30 June
ENP Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.